HighTower Advisors
VANI icon

HighTower Advisors’s Vivani Medical VANI Stock Holding History

HighTower Advisors’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,217
Closed -$24K – 2543
2019
Q3 		$24K Hold
1,217
– – ﹤0.01% 2261
2019
Q2 		$23K Hold
1,217
– – ﹤0.01% 2257
2019
Q1 		$23K Hold
1,217
– – ﹤0.01% 2175
2018
Q4 		$26K Hold
1,217
– – ﹤0.01% 2070
2018
Q3 		$55K Buy
+1,217
New +$49.1K ﹤0.01% 2116

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $85.5M AUM 3.46% 1-Year Est. Return

HighTower Advisors's VANI Position: Q4 2019 in Review

HighTower Advisors sold out of Vivani Medical (VANI) in Q4 2019, closing a stake of 1,217 shares — an estimated $24K sold.

HighTower Advisors first reported a position in VANI in Q3 2018 and held it in 5 quarters. The position peaked at $55K in Q3 2018. 30 funds tracked by Wall St. Rank hold VANI as of Q4 2019.

  • HighTower Advisors reported no remaining Vivani Medical position as of Q4 2019 after selling out during the quarter.
  • HighTower Advisors sold 1,217 Vivani Medical shares in Q4 2019, an estimated $24K.
  • HighTower Advisors first reported a position in Vivani Medical in Q3 2018 and held it in 5 quarters.
  • HighTower Advisors's Vivani Medical position peaked at $55K in Q3 2018.
  • 30 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2019.

Based on HighTower Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.